These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28062169)

  • 1. Plasmapheresis and other extracorporeal filtration techniques in critical patients.
    Daga Ruiz D; Fonseca San Miguel F; González de Molina FJ; Úbeda-Iglesias A; Navas Pérez A; Jannone Forés R
    Med Intensiva; 2017 Apr; 41(3):174-187. PubMed ID: 28062169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Extracorporeal detoxification (hemosorption, plasmapheresis and plasma exchange) in the intensive therapy of hemolytic disorders].
    Starikov AV; Romanova AF; Beschastnaia SP; Belaia TI
    Anesteziol Reanimatol; 1990; (4):16-7. PubMed ID: 2077958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced poison elimination in critical care.
    Ghannoum M; Gosselin S
    Adv Chronic Kidney Dis; 2013 Jan; 20(1):94-101. PubMed ID: 23265601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Methods of Molecular Transfusion in the Intensive Therapy of Critical States].
    Yaroustovsky MB; Abramyan MV; Krotenko NP; Komardina EV
    Vestn Ross Akad Med Nauk; 2016; 71(4):281-7. PubMed ID: 29297645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of outcomes and costs of extracorporeal blood purification therapies in critically ill COVID-19 patients.
    Dianaty S; Khodadadi S; Alimoghaddam R; Mirzaei A
    Ther Apher Dial; 2023 Jun; 27(3):505-516. PubMed ID: 36324189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Puncture of the internal jugular vein as an access for extracorporeal circulation in hemodialysis, hemoperfusion and plasma separation].
    Passlick J; Hein D; Grabensee B
    Med Welt; 1981 Jul; 32(29):1143-5. PubMed ID: 7266349
    [No Abstract]   [Full Text] [Related]  

  • 7. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
    Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
    G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of endotoxin from the blood by extracorporeal activated charcoal hemoperfusion in experimental canine endotoxin shock.
    Bende S; Bertók L
    Circ Shock; 1986; 19(2):239-44. PubMed ID: 3719924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasmapheresis: technique, complications and indications].
    Pruijm MT; Cherpillod A; Vogt B; Burnier M
    Rev Med Suisse; 2008 Mar; 4(147):581-2, 584-6, 588. PubMed ID: 18402016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemoperfusion and plasmapheresis complications].
    Perino GC; Grivet V
    Minerva Urol Nefrol; 1987; 39(2):161-3. PubMed ID: 3629414
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the Effects of Plasmapheresis, Hemoperfusion, and Convalescent Plasma Therapy on Inflammatory Factors in COVID-19 Patients.
    Akhlaghi SS; Alamdari S; Masrour H; Najafizadeh K; Parkhideh S; Hassanzadeh K; Ghadiani MH; Mirabootalebi FS; Hajifathali A
    Med J Islam Repub Iran; 2022; 36():142. PubMed ID: 36569400
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective removal of endotoxin from the blood by extracorporeal hemoperfusion with polymyxin B immobilized fiber.
    Hanasawa K; Tani T; Oka T; Yoshioka T; Aoki H; Endo Y; Kodama M
    Prog Clin Biol Res; 1988; 264():337-41. PubMed ID: 2837785
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective removal of plasma constituents potential application in the treatment of renal disease.
    Pineda AA
    Int J Artif Organs; 1985 Jul; 8 Suppl 2():39-42. PubMed ID: 2414232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of plasmapheresis and immunoadsorption in salvage therapy of rheumatological diseases].
    Boser M; Kielstein JT
    Z Rheumatol; 2016 Dec; 75(10):964-972. PubMed ID: 27807630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extracorporeal treatments for some autoimmune eye diseases].
    Razumova IIu; Safonova TN; Komov VV; Fedorov AA
    Vestn Oftalmol; 2010; 126(3):21-5. PubMed ID: 20608194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal blood purification in the management of patients with hepatic failure.
    Kaplan AA; Epstein M
    Semin Nephrol; 1997 Nov; 17(6):576-82. PubMed ID: 9353867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomodulation effects of extracorporeal circulation in apheresis.
    Malchesky PS; Nosè Y
    Semin Hematol; 1989 Apr; 26(2 Suppl 1):42-51. PubMed ID: 2658097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of extracorporeal hemo-correction on lipid peroxidation in patients in critical states].
    Chalenko VV; Zhilkina SV; Pastukhova NK; Kutushev FKh; Romanchishen AF
    Vestn Khir Im I I Grek; 2001; 160(3):55-9. PubMed ID: 11517792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenetic substantiation of extracorporeal detoxication in surgery.
    Ender LA; Lekhtman AM; Lobakov AI
    Biomater Artif Cells Artif Organs; 1990; 18(4):507-12. PubMed ID: 2285813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endotoxin adsortion as adjuvant therapy in gram negative severe sepsis].
    Candel FJ; Martínez-Sagasti F; Borges M; Maseda E; Herrera-Gutiérrez M; Garnacho-Montero J; Maynar FJ; Zaragoza R; Mensa J; Azanza JR
    Rev Esp Quimioter; 2010 Sep; 23(3):115-21. PubMed ID: 20844841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.